Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00638196 · ClinicalTrials.gov registry record · Phase 1
Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MS
A Phase 1 study, sponsored by University of Rochester.
- Terminated
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT00638196: Clinical Trial Phase 1 study, sponsored by University of Rochester.
NCT00638196 is a Phase 1 study that was terminated before completion, run by University of Rochester. The registered enrollment target is 9 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00638196, a Phase 1 study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
Several investigations have suggested that polyunsaturated fatty acids may promote therapeutic effects in MS. This pilot study will determine whether omega-6 polyunsaturated fatty acids (PUFAs),in the form of linoleic acid,can reduce disease activity and prevent disability progression in patients with relapsing MS.This study will seek to measure disease activity as seen on MRI scans in addition to measuring relapse rates.
Interventions
- DRUG Linoleic Acid/Oleic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-03 |
| Est. Completion | 2012-09 |
| Phase | Phase 1 |
Why NCT00638196 stopped before completion
NCT00638196 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which Linoleic Acid/Oleic Acid is the first listed.
NCT00638196 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00638196 about?
NCT00638196 is a clinical study titled "Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MS". Several investigations have suggested that polyunsaturated fatty acids may promote therapeutic effects in MS. This pilot study will determine whether omega-6 polyunsaturated fatty acids (PUFAs),in the form of linoleic acid,can reduce disease activity and prevent disability progression in patients wi...
What is the current status of trial NCT00638196?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2008-03. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00638196?
The interventions under investigation include: Linoleic Acid/Oleic Acid (DRUG).
Who is sponsoring clinical trial NCT00638196?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00638196's enrollment target sits among peer trials
9 1955th of 2000 higher than 42 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia